Provenance du réseau au premier degré de Philip J. Davis
| Entité | Type d'entité | Industrie | |
|---|---|---|---|
Chay Enterprises, Inc.
 Chay Enterprises, Inc. Real Estate DevelopmentFinance Chay Enterprises, Inc. serves in real estate development. It operates in the real estate industry and the company primarily acquires tracts of raw land and develops them into residential lots for sale to homebuilders and individuals. The firm currently own 32 residential building lots in Fall River County, South Dakota. Chay was founded on March 29, 1996 and is headquartered in Littleton, CO.
1
| Extinct | Real Estate Development | 1 |
Ivory Capital Corp.
1
| Extinct | Financial Conglomerates | 1 |
Graphique Sociétés connectées au second degré
Relation dans plusieurs entreprises
Sociétés connectées à Philip J. Davis via son réseau personnel
| Société | Secteur | Personnes liées | Poste principal |
|---|---|---|---|
| ONCOTELIC THERAPEUTICS, INC. | Biotechnology | Director/Board Member | |
| ONCOLOGY PHARMA INC. | Pharmaceuticals: Major | Corporate Officer/Principal | |
| DELCATH SYSTEMS, INC. | Medical Specialties | Director/Board Member | |
| ATHENEXPAR | Pharmaceuticals: Major | Corporate Officer/Principal | |
| CHELSEA THERAPEUTICS INTERNATIONAL LTD. | Biotechnology | Founder | |
DMI Life Sciences, Inc.
 DMI Life Sciences, Inc. Pharmaceuticals: MajorHealth Technology Part of SOBR Safe, Inc., DMI Life Sciences, Inc. develops pharmaceutical products and medical devices. The company is based in Greenwood Village, CO. DMI Life Sciences was acquired by Chay Enterprises, Inc. on March 04, 2010 for $22.60 million. The company was founded by Michael E. Macaluso. | Pharmaceuticals: Major | President | |
Hoffmann-La Roche, Inc.
 Hoffmann-La Roche, Inc. BiotechnologyHealth Technology Hoffmann-La Roche, Inc. manufactures pharmaceutical drugs. Its products include influenza fighter Tamiflu, controversial acne medication Accutane, HIV inhibitor Fuzeon, obesity drug Xenical, and hepatitis C therapy Pegasys. The company was founded in 1896 Roche and is headquartered in Nutley, NJ. | Biotechnology | Chief Tech/Sci/R&D Officer | |
Shearwater Corp.
 Shearwater Corp. Pharmaceuticals: MajorHealth Technology Part of Nektar Therapeutics, Shearwater Corp. is a company that provides research services focused on health care applications of advanced PEGylation. The company is based in Huntsville, AL. The company was founded by James R. Hudson, J. Milton Harris. Shearwater was acquired by Nektar Therapeutics on July 02, 2001 for $164.50 million. | Pharmaceuticals: Major | Corporate Officer/Principal | |
| Concordia University | College/University | Graduate Degree | |
| Rutgers State University of New Jersey | College/University | Graduate Degree | |
| Lafayette College | College/University | Undergraduate Degree | |
| The University of Waterloo | College/University | Undergraduate Degree | |
GE HealthCare Ceská republika sro
 GE HealthCare Ceská republika sro Medical DistributorsDistribution Services Part of General Electric Co., GE Medical Systems Ceská Republika sro is a company based in Prague, Czechia. The Czech company distributes and services medical equipment. | Medical Distributors | Sales & Marketing | |
| AMPIO PHARMACEUTICALS, INC. | Pharmaceuticals: Major | President | |
| Western Imaging Technologies | President | ||
| Accel Holdings, Inc. | President | ||
| AVALO THERAPEUTICS, INC. | Pharmaceuticals: Major | Chairman | |
| CELLECTAR BIOSCIENCES, INC. | Pharmaceuticals: Major | Chief Executive Officer | |
| Eboo Pharmaceuticals, Inc. | Director/Board Member | ||
| University of Saskatchewan College of Medicine | College/University | Doctorate Degree | |
Ballantyne Therapeutics, Inc.
 Ballantyne Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Ballantyne Therapeutics, Inc. manufactures pharmaceuticals. The private company is based in Charlotte, NC. | Pharmaceuticals: Major | Director/Board Member | |
Atlantic Research Group, Inc.
 Atlantic Research Group, Inc. Miscellaneous Commercial ServicesCommercial Services Atlantic Research Group, Inc. operates as a rare disease-focused contract research organization that provides comprehensive clinical program development services ranging from pre-launch consulting to commercialization. It offers strategic consulting, clinical trial management services, clinic data and analytics solutions, pharmacovigilance and medical monitoring. The company was founded by Paul Bishop and Lyle Camblos in 2004 and is headquartered in Charlottesville, VA. | Miscellaneous Commercial Services | Director/Board Member | |
Nirogy Therapeutics, Inc.
 Nirogy Therapeutics, Inc. BiotechnologyHealth Technology Nirogy Therapeutics, Inc. is an American biotechnology company that operates in the healthcare industry. The company is based in N/A. The company was founded in 2014 by Vincent Sandanayaka, Jaime Escobedo. Simon C. Pedder has been the CEO of the company since 2022. | Biotechnology | Chief Executive Officer |
Statistiques
Internationale
| Etats-Unis | 24 |
| Canada | 4 |
| République Tchèque | 2 |
Sectorielle
| Health Technology | 17 |
| Consumer Services | 6 |
| Health Services | 2 |
| Distribution Services | 2 |
| Commercial Services | 2 |
Opérationnelle
| President | 12 |
| Director/Board Member | 10 |
| Corporate Officer/Principal | 5 |
| Chief Executive Officer | 5 |
| Independent Dir/Board Member | 3 |
Relations les plus connectées
| Insiders | |
|---|---|
| Simon Pedder | 19 |
| Donald B. Wingerter | 10 |
- Bourse
- Insiders
- Philip J. Davis
- Connexions Sociétés
